Field
This disclosure relates to a sensor and method for analyzing bilirubin in a sample.
Description
The detection of abnormal serum bilirubin levels can be used for the detection of a variety of health issues ranging from jaundice in children to liver disease in adults. For newborn infants, raised serum bilirubin levels (hyperbilirubinemia) affect between 50 percent of term and 80 percent of preterm infants, leading to jaundice within their first week of life. Akobeng, A. “Neonatal Jaundice,” Am. Fam Physician 2005, 71(5):947-948. In addition to producing jaundice, unconjugated bilirubin can penetrate the blood-brain barrier of newborn infants. Newborn infants with high bilirubin levels in the brain may develop acute, chronic or subtle bilirubin encephalopathy. These disorders can produce long-term debilitating effects such as hearing loss, movement disorders, auditory dysfunction, and oculomotor impairments, or in severe cases, seizures or death. In adults, raised bilirubin serum levels may be a symptom of a number of serious illnesses such as hepatitis, cirrhosis, fatty liver disease, or liver cancer. For these reasons, a quick and accurate assay for measuring serum bilirubin has significant implications for public health.
When sampling blood bilirubin, an optical assay may be desirable as a method for an accurate and quick testing. Some exemplary techniques for facilitating the binding and measurement of serum bilirubin levels are found in U.S. Pat. No. 3,569,721 “Measuring Bilirubin in Blood Using Light at Two Wavelengths,” U.S. Pat. No. 4,069,017 “Colorimetric Assay for Bilirubin,” U.S. Pat. No. 4,412,005 “Determination of Total Bilirubin,” and U.S. Pat. No. 4,788,153 “Method for the Determination of Bilirubin and an Element Useful Therein,” the entirety of which are incorporated herein by reference. U.S. Application Nos. 62/096,178 and Ser. No. 14/978,292, entitled “Combination Optical Hemoglobin and Electrochemical Lead Assay,” are also incorporated herein by reference.
In one aspect, a sensor for measuring bilirubin in a liquid sample comprises a filter; a reservoir having a top surface and a bottom surface; at least one transparent portion, the transparent portion forming at least a part of the bottom surface of the reservoir; and wherein a portion of the top surface comprises a reflector, is disclosed.
In some embodiments, the substrate further comprises a base layer forming the bottom surface of the reservoir, wherein the at least one transparent portion forms at least a portion of the base layer; a reflective layer having a void extending through a thickness of the reflective layer and wherein at least a portion of the reflective layer comprises a reflector; a filter layer wherein at least a portion of a bottom surface of the filter layer comprises a portion of the top surface of the reservoir; a spacer layer having a void extending through a thickness of the layer and wherein a portion of a bottom surface of the spacer layer may comprise a portion of the top surface of the reservoir; a lid, the lid having a void extending through a thickness of the lid, the lid having a bottom surface, and wherein at least a portion of the bottom surface of the lid forms at least a portion of the top surface of the spacer layer; and wherein the reflective layer is disposed on the base layer, the filter layer and spacer layer are disposed on the reflective layer, and the lid is disposed on the spacer layer.
In some aspects descried herein, a sensor for measuring bilirubin in a liquid sample comprises an optically transparent portion; a one or more electrodes formed on the base layer; a reflective layer, the reflective layer comprising: at least a portion of a reservoir, the reservoir configured to receive a sample to be analyzed.
In some embodiments, the sensor further comprises a filter layer disposed between at least a portion of a bottom surface of a lid and/or spacer layer and a top surface of a reflective layer.
In some embodiments, the sensor further comprises a spacer layer having a void extending through a thickness of the layer and wherein a portion of a bottom surface of the spacer layer may comprise a portion of the top surface of the reservoir;
In some embodiments, the sensor further comprises a spacer layer between the filter layer and the lid, the spacer layer having a void formed therein, the void extending through a thickness of the layer and wherein the size, shape, or thickness of the spacer layer determine the size, shape, or thickness of at least a portion of the filter layer.
In some embodiments, the sensor further comprises a lid, the lid having a void extending through a thickness of the lid, the lid having a bottom surface, and wherein at least a portion of the bottom surface of the lid forms at least a portion of the top surface of the spacer layer.
In some embodiments the filter inhibits the passage of erythrocytes, white blood cells, and/or platelets.
In some embodiments, at least a portion of the filter may be compressed by the lid and/or spacer layer.
In some embodiments a bilirubin binding material has been sputtered, printed, sprayed, air brushed, or otherwise deposited on at least a portion of the reflective layer.
In some embodiments, the bilirubin binding material is a cationic copolymer and gelatin.
In some embodiments, the reflector material comprises barium sulfate.
In some embodiments, the sensor comprises at least one electrode disposed on a bottom surface of the reservoir and at least one electrical contact disposed on the substrate, and wherein the at least one electrode is in electrical communication with the at least one electrical contact.
In some embodiments, the sensor comprises at least one electrode disposed on a bottom surface of the reservoir and at least one electrical contact disposed on the base layer, and wherein the at least one electrode is in electrical communication with the at least one electrical contact.
In another aspect described herein, a method for measuring bilirubin in a sample comprises inserting a sensor into an analyzer, the sensor comprising a filter and the analyzer comprising a light source and a detector; introducing the liquid sample to a sensor; filtering the sample using the filter; illuminating the liquid sample through a portion of the sensor using the light source; measuring a reflectance of the liquid sample at one or more wavelengths using a detector in the analyzer; and determining an amount of bilirubin based on the measured reflectances.
In some embodiments, the sample is whole blood and the filter inhibits the passage of erythrocytes.
In some embodiments, the sensor comprises a reflective layer, and reflectance is measured by measuring light reflected off the reflective layer.
In some embodiments, the method further comprises taking a reference measurement in the sensor when no sample is present in the sensor.
In some embodiments a reflectance is computed by comparing an intensity measured at the detector to a reference intensity.
In some embodiments the reference intensity is obtained by inserting a reference sensor into the analyzer, illuminating reference sensor, and measuring an intensity of light received at the detector.
In some embodiments, internally reflected stray light is measured by detecting at the detector the intensity of light reflected off a light absorbing surface as the sensor is inserted into or withdrawn from the analyzer, the method further comprising subtracting the measured internally reflected stray light from the reference intensity and the measured intensity of the sample to obtain a result which adjusts for internally reflected stray light.
In some embodiments, determining the bilirubin concentration comprises: subtracting the secondary wavelength absorbance value from the adjusted target wavelength absorbance value to obtain a result that is corrected for hemoglobin and plasma interference, the method further comprising comparing the resulting value to a bilirubin calibration curve to determine the bilirubin concentration.
In some embodiments, the target wavelength is approximately 480 nm.
In some embodiments, the secondary wavelength is approximately 525 nm.
In the following detailed description, reference is made to the accompanying drawings, which form a part hereof. In the drawings, similar symbols typically identify similar components, unless context dictates otherwise. The illustrative embodiments described in the detailed description, drawings, and claims are not meant to be limiting. Other embodiments may be utilized, and other changes may be made, without departing from the spirit or scope of the subject matter presented herein. It will be readily understood that the aspects of the present disclosure, as generally described herein, and illustrated in the Figures, can be arranged, substituted, combined, separated, and designed in a wide variety of different configurations, all of which are explicitly contemplated herein.
Disclosed in the present application are a sensor and methods for analyzing a liquid sample for bilirubin. In some embodiments, the sample is a vertebrate or mammalian blood sample, and the sample is placed on the sensor of the present disclosure, the sensor being readable using an analyzer. In some embodiments, the sample is analyzed for bilirubin concentration and results may be provided to a user in milligrams of bilirubin per deciliter of sample (mg/dL). In some embodiments, the sample is analyzed for bilirubin concentration using an optical measurement. Common components in whole blood such as hemoglobin or erythrocytes can inhibit the accurate optical measurement of serum bilirubin levels. In particular, hemoglobin demonstrates high absorbance at the same optical wavelengths as bilirubin. In some embodiments, the apparatuses and methods of the present disclosure do not require pretreating a whole blood liquid sample to remove or alter hemoglobin or erythrocytes prior to introduction of the sample to a sensor.
As depicted in
As shown, some of the contacts disposed on first end 101 may be spaced back from the edge of first end 101, for example, working electrode contacts 121, and counter electrode contact 123. Other contacts may be disposed directly on the edge, for example, sensor ID electrode contact 122 and sensor insertion contact 124. Moreover, in some embodiments, the lengths and widths of the contracts may vary from contact to contact. In some embodiments, greater than five or fewer than four contacts may be used.
In operation, the working electrode contact 121 provides an electrical connection between the working electrode 125 and the analyzer which allow the analyzer to apply a voltage to the working electrode contact 121 and thus to the working electrode 125. the sensor ID electrode contact 122, when inserted into the analyzer, makes electrical contact with a corresponding contact in electrical contact structure 230 within the analyzer sensor port 210. The resulting electrical connection and electrical properties allow the analyzer 200 to recognize the optical sensor 100 as a bilirubin sensor. In some embodiments, the sensor ID electrode contact 122 provides additional information such as a manufacturing batch number or specific calibration information for the sensor 100 when it is connected to the sensor contacts in electrical contact structure 230 of the analyzer 200. In some embodiments, the counter electrode contact 123 provides a signal to the analyzer when the working electrode 125 and counter electrode 131 detects that the reflective layer is sufficiently wetted by the plasma. A reference voltage is generally applied to the counter electrode 131 from the analyzer. When a sample is applied to the sensor 100, the sample contacts the counter electrode 131, the conductivity of the sample alters a voltage or current or resistance measured in the analyzer based on the signal from the counter electrode 131.
In some embodiments, the sample contacts the counter electrode 131 and the working electrode 125. The conductivity of the sample can allow a current to flow through the sample between the counter electrode 131 and the working electrode 125, based on a reference voltage applied to the counter electrode. The change in current or resistance sensed between the counter electrode 131 and the working electrode 125 measured in the analyzer can be used to generate a signal that the sensor has been wetted by the sample, and is ready for analysis.
A user initiates a bilirubin measurement routine on an analyzer 200. Light source(s) 321, 322 pulse prior to the insertion of a sensor. The sensor is placed on sensor support structure 220 for insertion into sensor port 210. The analyzer 200 detects the presence of sensor 100 when sensor insertion contact 124 makes an electrical connection with sensor contacts in electrical contact structure 230. As discussed above, the sensor ID electrode contact 122 identifies the sensor and provides calibration information.
Each layer of sensor 100 will now be described in greater detail with reference to
Base layer 110 may comprise a transparent substrate that permits optical signals to pass there through. In some embodiments, the base layer 110 is formed entirely of a transparent material. In some embodiments, the base layer 110 is only partially comprised of a transparent material, the transparent material forming a transmission window 111 through the base layer 110 to allow for optical interrogation of a sample. In some embodiments, the transmission window is disposed between two separate electrodes, the working electrode 125 and the counter electrode 131 along a longitudinal axis of base layer 110 (see
The dielectric layer 130 is also disposed on top of base layer 110. The dielectric layer 130 may be an electrically insulating material, for example, a polymeric material. The dielectric layer 130 may serve to protect and isolate the active surfaces of the contacts 121-124 from the sample 190 as it flows into the reservoir of the reflective layer 150. In some embodiments, the dielectric layer 130 may also form the channel for the deposition of the reflective layer 150 as it provides for the outer bounds of the reflective layer 150. Modulating the height of the dielectric layer may also allow for increased or decreased thickness of the reflective layer as is necessary. The spacing of the dielectric layer may also allow for enhanced or decreased volume of the sample reservoir in the reflective layer 150 as is necessary.
The reflective layer 150 is disposed on an upper surface of base layer 110. In some embodiments, the reflective layer is disposed on all or a portion of the base layer 110. In some embodiments, reflective layer 150 is disposed on the transmission window 111 of the base layer 110 to allow reflection of light passing through the transmission window 111 during analysis. Reflective layer 150 may be generally rectangular in shape with a width less than or equal to the width of the base layer 110 and a length less than the length of base layer 110. One of skill in the art will understand according to the present disclosure that the reflective layer 150 may be round, square, diamond, or any shape suitable for use with the transmission window 111. One of skill in the art will also understand according to the present disclosure that various thicknesses may be used, for example, thicknesses of 0.0001″, 0.0005″, 0.001″, 0.005″, 0.010″, or any thickness there between. As will be described in greater detail below with regard to
In some embodiments, the reflective layer 150 is defined at its lateral edges by the adhesive and dielectric layers at its horizontal edges, by the base layer 110 at its bottom surface, and by the filter 160 and spacer layers 170 at its top surface. The reflective layer 150 also comprises at least a portion of the reservoir for the sample following its passage through filter layer 160. The thickness of the dielectric layer 130 along with the thickness of the adhesive layer 140 that binds the dielectric layer 130 to the adjacent layers may define the depth of the reflective layer, the depth of which impacts the sensor's ability to be used for optical bilirubin measurement given that insufficient thickness of the reflective layer may prevent sufficient passage of light through the sample for accurate optical bilirubin measurement. In some embodiments, the deposition method used for reflective layer 150 may determine the thickness of the reflective layer. In some embodiments, at least a portion of the reflective layer comprises a porous, reflective deposited material. The porous reflective deposited material can be a bilirubin binding material. In some embodiments, the porous reflective deposited material comprising the reflective layer 150 is a sprayed, sputtered, printed, or otherwise deposited ink formulation with a reflector. In some embodiments, the porous reflective deposited material 1 may be made with a material that can absorb the liquid sample and whose reflectance changes as the sample is absorbed. In some embodiments the porous reflective deposited material of the reflective layer 150 is a barium sulfate reflective material. The barium sulfate reflective material can comprise a gelatin, a cationic copolymer, and/or other components as necessary to act as a bilirubin binding material and to provide reflectance signals to the analyzer 200. The barium sulfate reflective material can be similar to those described in U.S. Pat. Nos. 4,069,017; 4,412,005; and U.S. Pat. No. 4,788,153 In some embodiments, a material that binds bilirubin may be sprayed, sputtered, printed, or otherwise deposited on the reflective layer 150. In some embodiments, the bilirubin binding material is a cationic copolymer and gelatin. The depth of the reflective layer 150, should be sufficiently thick so as to ensure that most of the light is reflected back out of sensor 100. If the porous reflective layer 151 lacks sufficient depth, insufficient light will be reflected out of sensor 100 and optical measurements will be inaccurate. Further, as some embodiments may require a minimum amount of light absorbance or absorption, insufficient depth or thickness of the porous, reflective deposited material may also produce inaccurate optical measurements. This effect can be minimized by ensuring that porous reflective material layer 151 contains sufficient depth or thickness, for example, 0.0005″ or 0.001″.
The filter layer 160 is disposed between the reflective layer 150 and the spacer layer 170. The filter layer 160 is positioned between the reflective layer 150 and the spacer layer 170 so as to align, at least in part, with a sample inlet 181, formed in the lid layer 180, which will be described in greater detail below. The filter layer 160 comprises a filter that inhibits the passage of molecules and/or compounds that hinder an accurate optical measurement of bilirubin in a liquid sample. Some constituents in whole blood, such as hemoglobin have significant absorbance of optical signals. The light absorbance of the whole blood constituents can mask or interfere with a measurement of another analyte of interest, such as bilirubin. In some embodiments, the filter may inhibit the passage of cells (e.g. erythrocytes) which may contain quantities of molecules, such as hemoglobin, which can interfere with optical measurements of bilirubin. In some embodiments, the filter layer 160 has a large surface area to ensure the efficient passage of plasma into the portion of the reservoir in the reflective layer 150. To ensure that sufficient plasma volume has been reached, electrodes 125 and 131 are disposed on base layer 110 and oriented so as to detect when the reflective layer is wetted by plasma. This may be particularly useful for liquid samples with an appreciable concentration of contaminating molecules that may clog the filter, such as neonatal blood samples with high erythrocyte concentrations. In some embodiments, a keyhole filter configuration may prevent the leakage of contaminants such as erythrocytes into the reflective layer 150. In some embodiments, firm pressure is provided by the spacer layer 170 to prevent the leakage of contaminating molecules and to aid in the wicking of the plasma toward the transmission window. In some embodiments, areas of the filter layer 160 are compressed by pressure placed upon the lid 180 and/or spacer layer 170 to prevent leakage of erythrocytes into the portion of the reservoir in the reflective layer or the portion of the reservoir in the filter layer and to enhance wicking of the blood plasma into the transmission window as demonstrated in
The spacer layer 170 is disposed on top of the filter layer 160. The spacer layer 170 may be made from white polyester or any other suitable material. In some embodiments, a suitable material may be one that can be used as a diffuse reflector. In some embodiments, the material may be hydrophilic, or coated with a hydrophilic substance. In some embodiments the spacer layer 170 is approximately 0.001, 0.005, 0.01, 0.15, 0.2 inches thick or more, or any thickness there between. The size, shape, or thickness of the spacer layer 170 and/or the adhesive layer 140 affects the volume of contiguous filter which is accommodated on the sensor, as during construction of the sensor 100, a portion of the spacer layer 170 is disposed directly on the filter layer 160, and will compress the portion of the filter layer 160, as shown in
A lid layer 180 is disposed on top of spacer layer 170. The lid layer 180 is configured in size and shape to have similar width and length dimensions as pacer layer 170. In some embodiments, the lid layer 180 is 0.001, 0.005, 0.01, 0.02 inches thick or more, or any value there between. Lid layer 180 may be comprised of a plastic or other suitable material. In some embodiments, lid layer 180 is coated with a hydrophilic substance so that the reservoir can be more easily filled with the sample 190. In some embodiments, lid layer 180 and/or spacer layer 170 may also be formed of a clear, transparent, or translucent material. The use of a clear, transparent, or translucent material may facilitate a visual indication to the user when the reservoir is filled. In some embodiments, lid layer 180 may be opaque so as to shield the optical measurements that will be discussed below from interference from ambient light. It will be noted, however, that a clear lid layer 180 and/or spacer layer 170 may be used and obtain an accurate optical measurement according to the present disclosure. The lid layer 180 provides an upper boundary on a sample reservoir within sensor 100 to prevent evaporation of the sample 190. Lid layer 180 also includes a sample inlet 181 and a vent 182 formed as voids extending through a thickness of the lid layer 180 as well as through the thickness of spacer layer 170 below. The relative positioning of the inlet 181 and vent 182 depicted in
Following the measurement of the reference sample, the sample 190 to be analyzed is then introduced to the sensor 100 at sample inlet 181. The sample 190 may be a sample of whole blood. Sample 190 moves through the filter layer 160. The filter layer 160 excludes erythrocytes and other unwanted sample components. One of ordinary skill guided by this disclosure would recognize that any suitable type of filter or filtering material may be used to filter out undesirable sample components. The bilirubin containing plasma from sample 190 that has passed through filter layer 160 arrives in the reflective layer 150. The relatively large available filter surface area 160 allows for the necessary plasma volume to enter the reservoir. Neonates have a very high concentration of red blood cells that can clog smaller filter surface areas. The filter further comprises a compressed filter region 162 under the lid 180 and/or spacer layer 170 to seal the erythrocytes from moving around the edge, and aids in the wicking of the plasma into the transmission window. The void volume of the crushed filter or the sample reservoir is defined by the other sensor components, which may include the lid 180 and/or spacer layer 170. Capillary action facilitates the efficient wicking of plasma through the reflective layer 150 to the contacts.
Vent 182 is provided to prevent overfilling and to allow air to escape as the sample reservoir in the reflective layer 150 is filled. The thickness of dielectric layer 130 and the adhesive layer 140 may define the depth between the base layer 110 and the reflective layer 150. In some embodiments, the reservoir depth in the reflective layer 150 is approximately 0.004 inches deep. The filter, which may be setup in a keyhole configuration, prevents erythrocytes in the liquid sample 190 from passing through to the reservoir. Plasma containing an analyte of interest, such as bilirubin, passes through the filter and wicks into the reflective layer. The plasma wicking into the filter layer 160 and the reflective layer 150 contacts the working electrode 125 and the counter electrode 131. When the working electrode 125 and the counter electrode 131 is contacted with the plasma the analyzer identifies that the working electrode 125 and counter electrode 131 is wetted with the plasma, and initiates the measurement process. After a brief delay to ensure stabilization of the optical reflectance, the one or more light sources, 321 and/or 322, initiate alternating pulsing to determine the filled sensor reflectance at one, two or more distinct wavelengths. As discussed below, the light source(s) 321 and/or 322 may emit light at a single wavelength, two or more distinct wavelengths, or a broad spectrum of wavelengths of light. A person of skill in the art will recognize that any suitable wavelength, wavelengths, or spectrum of wavelengths may be used. A person of skill in the art will also recognize that additional light sources may be added or removed as necessary.
In some embodiments, the reflectance of the sample is then measured at both a target and secondary wavelength. After both wavelengths are measured, the reflectance of the secondary wavelength is subtracted from the target wavelength to eliminate the effect of contaminants. This corrected value is then compared to a bilirubin calibration curve and an analyte concentration is calculated. In some embodiments, the target wavelength is approximately 480 nm and the secondary wavelength is 525 nm. This calculation will be described in greater detail below in conjunction with Equation 1 and
For example, when a sample is applied to the sample port 481, the sample flows through the filter layer 460, wherein erythrocytes are filtered out. The sample then flows into the reflective layer 450, wherein the sample comes into contact with working electrode 425 and reference electrode 433. When sufficient sample as contacted the working electrode 425 and the reference electrode 433, a circuit path is created between the working electrode 425 and the reference electrode 433. The referenced electrode is maintained at a voltage from the analyzer via the associated contacts in analyzer 200, and a current flows between the working electrode 425 and the reference electrode 433. The analyzer detects this current at the associated contacts on the sensor 400, and interprets the sensor 400 has having been wetted. As the sample continues to wick along the reflective layer, the sample will contact electrode 431. This will create a second current flow path between the reference electrode 433 and counter electrode 431. The analyzer 200 detects this current at the contact associated with the counter electrode contact 423, and determines that sufficient sample is above the transmission window 411, and that sample is ready to be measured.
The process moves to block 1002, where the initiated analyzer 200 send a signal to light source(s) 321 and/or 322 to pulse light prior to the full insertion of a sensor 100 or 400.
The process moves to block 1003, wherein the analyzer 200 detects the reflected light from the light sources 321, 322 in the detector 310 and uses the reflected light to set a background reflectance, or a reference reflectance. For example, the analyzer 200 pulses the light sources 321, 322, and reflected light travels through the transmission window 111, through the collection lens 311, and into the detector 310 to provide reference “no sensor inserted” optical values (e.g. BDark and GDark). The definitions of exemplary optical value labels such as BDark and GDark are defined below under Equation 1. In some embodiments, optical values at additional, alternative, or spectrums of wavelengths may be measured. In some embodiments, the light source(s) may pulse light prior to the full insertion of the sensor 100 or 400 into the sensor port 210 of the analyzer 200 as the sensor 100 or 400 is placed on the sensor support structure 220.
The process moves to block 1004, wherein the sensor 100 or 400 is inserted into the sensor port 230. In block 1005, the analyzer 200 detects the presence of sensor 100 or 400 when sensor insertion contact 124 and other contacts make an electrical connection with sensor contacts in electrical contact structure 230. As the sensor 100 or 400 is inserted, the sensor insertion contact 124 can complete a circuit with the electrical contact structure 230. The analyzer 200 receives a current signal from the completed circuit, and this signal indicates to the analyzer 200 that a sensor has been inserted.
In block 1006, sensor ID electrode contact 122 identifies the sensor as a bilirubin sensor and may provide calibration information. In block 1007, the light source(s) 321 and/or 322 pulse light into the sensor 100 or 400 through the transmission window 111. In block 1008, the light is reflected through the transmission window 111, collected by the collection lens 311, and enters the detector 310 to determine optical values for an empty sensor (e.g. BEmpty and GEmpty). In some embodiments, the empty sensor may not contain a sample. In some embodiments, the empty sensor may comprise a bilirubin-free sample.
In block 1009, a blood sample 190 is added to sample inlet 181 on top of filter layer 160. The process moves to block 1010, wherein the bilirubin-containing plasma passes through a filter layer 160, where the erythrocytes are filtered out or retained in the filter layer 160, and the filtered sample, or plasma, moves into the reflective layer 150. The plasma contacts the working electrode 425 and the reference electrode 433 and generates a signal, which the analyzer interprets as the sensor 400 is wetted.
The process moves to block 1011, wherein the filtered sample or plasma continues to wick along the reflective layer 450, where the sample contacts counter electrode 431. This creates a current flow path, as described elsewhere herein, which generates a current and signal which the analyzer 200 interprets as the sample being ready for measurement. For example, when sufficient sample is in the reflective layer 450 for optical measurements, working electrode contact 123 and the counter electrode 131 (or their counterpart electrodes 425 and 431) send a signal to the analyzer 200.
The process moves to block 1012 wherein the light sources 321, 322 emit light, which passes through the transparent window 411 and into the reflective layer 450, where the sample is located. The light reflects and/or scatters through the reflective layer 450. A portion of the light can be absorbed by the bilirubin within the reflective layer 450.
The process moves to block 1013, wherein the reflected light from the reflective layer 450, and possibly the filter layer 460 depending on the scattering of the light within the reflective layer 450, is reflected back through the transmission window 111, 411, and are detected in the detector 310. The detector 310 measures the intensity of the light reflected through transmission window 111 to determine optical values for the sample 190, (e.g., BSample and GSample).
The process moves to block 1014, wherein the analyzer 200 utilizes the relevant optical sensor values and inputs them into Equation 1 or an equivalent equation or formula to calculate a measured signal value. In block 1015, the measured signal value is input into an equation derived from a bilirubin calibration curve to determine the concentration of bilirubin in the blood sample 190, as will be described herein below.
Equation for Converting Optical Data into a Measured Signal Value
The apparatus and methods disclosed herein for making an optical bilirubin measurement of a treated blood sample may be modified to allow for measurement with different geometries. For example, throughout this application, reference has been made to optically measuring for bilirubin concentration using a light source and detector positioned generally below the sensor wherein the light from the light source passes upward through the sample and is reflected back down to the detector. This is merely exemplary. One of skill in the art will understand, according to the principles herein disclosed, that the light source and detector could be positioned generally above the sensor. In some embodiments, the light source may be positioned on one side of the sensor and the detector could be positioned on the opposite side of the sensor such that the light emitted travels through a transparent portion of the lid or through a hole in the lid, through the sample, and through a transparent portion on the base of the sensor.
Accordingly, the embodiments and principles described above may be used to measure the bilirubin concentrations in a blood sample using a single sensor and analyzer.
A sensor 400 and analyzer 200 incorporating the above-described principles for optically measuring bilirubin has been developed and tested yielding the following results. The analyzer was configured to calculate bilirubin using a preset bilirubin calibration curve.
The light intensity of a targeted and secondary wavelength reflected from the sensor 400 was measured before and after the sample was introduced. These wavelengths were approximately 480 nm and 525 nm respectively. The before and after intensity measurements were used to correct for stray and background absorbance. The adjusted 525 nm absorbance value was then subtracted from the targeted 480 nm wavelength. The concentration of bilirubin was determined using the calibration curve presented above. The same samples compared to reference values for. As shown in
The foregoing description details certain embodiments of the systems, devices, and methods disclosed herein. It will be appreciated, however, that no matter how detailed the foregoing appears in text, the systems, devices, and methods can be practiced in many ways. As is also stated above, it should be noted that the use of particular terminology when describing certain features or aspects of the embodiments disclosed herein should not be taken to imply that the terminology is being re-defined herein to be restricted to including any specific characteristics of the features or aspects of the technology with which that terminology is associated.
It will be appreciated by those skilled in the art that various modifications and changes may be made without departing from the scope of the described technology. Such modifications and changes are intended to fall within the scope of the embodiments. It will also be appreciated by those of skill in the art that parts included in one embodiment are interchangeable with other embodiments; one or more parts from a depicted embodiment can be included with other depicted embodiments in any combination. For example, any of the various components described herein and/or depicted in the Figures may be combined, interchanged or excluded from other embodiments.
With respect to the use of substantially any plural and/or singular terms herein, those having skill in the art can translate from the plural to the singular and/or from the singular to the plural as is appropriate to the context and/or application. The various singular/plural permutations may be expressly set forth herein for sake of clarity.
It will be understood by those within the art that, in general, terms used herein are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that virtually any disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” will be understood to include the possibilities of “A” or “B” or “A and B.”
While various aspects and embodiments have been disclosed herein, other aspects and embodiments will be apparent to those skilled in the art. The various aspects and embodiments disclosed herein are for purposes of illustration and are not intended to be limiting.
Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57. This application claims the benefit of U.S. Provisional Application No. 62/273,220 filed on Dec. 30, 2015.
Number | Date | Country | |
---|---|---|---|
62273220 | Dec 2015 | US |